Introduction
Beginning in December 2019, a serial pneumonia outbreak reported in Wuhan City, Hubei Province, China. Further investigations revealed it was a new type of coronavirus, which was termed COVID-19. Symptoms are variable and nonspecific, include dry cough, fever, dyspnea, fatigue, myalgia, and anosmia1. The real-time reverse-transcription polymerase chain reaction (rRT-PCR) test is the current diagnostic method for confirming infection, performed using nasal or pharyngeal swab specimens.
CT thorax, as a routine imaging tool for pneumonia diagnosis, is of great importance in the early detection
and treatment of patients affected by COVID-19. It may detect the early parenchymal abnormalities in the
absence of positive rRT-PCR at initial presentation 2. Numerous classical chest CT findings of this disease were described such as bilateral multi-lobar ground-glass opacification (GGO) with a prevalent peripheral or posterior distribution, mainly in the lower lobes, and sometimes consolidative opacities superimposed on GGOs could be found 3. Up to our knowledge, bronchiectasis is not a classical finding in COVID-19 pneumonia with a paucity of reporting its development and progression during the disease.